BioTech, Drug Development and Medical Technology

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

BioTech

Drug Development

Medical Technology

Seamless Therapeutics Launches with $12.5M Seed Financing to Advance Transformative Gene Editing Platform Based on Programmable Precision Designer Recombinases

Digital Health Global

MARCH 16, 2023

We believe our pioneering technology will allow us to shatter the boundaries that exist in gene editing methods today,” said Anne-K. Both Wellington and Forbion are visionaries and highly experienced biotech investors, and we look forward to working closely with them in our efforts to transform the gene editing landscape.” “Our

Life Science

Life Science Pharmaceuticals BioTech Drug Development

Q&A with Rami Rajab and Inna Nadelwais, Mecomed

Healthcare Innovation Consortium

OCTOBER 24, 2023

We aim to bring together relevant stakeholders, including payers, providers, patients groups, and biotech and when and where needed we cooperate with pharma, to be the one voice of the industry. Inna: Our aim is to improve patient and clinician access to modern, innovative and reliable medical technology.

BioTech

BioTech Drug Development Healthcare Innovation Medical Technology

Connected Health Pulse

Seamless Therapeutics Launches with $12.5M Seed Financing to Advance Transformative Gene Editing Platform Based on Programmable Precision Designer Recombinases

Q&A with Rami Rajab and Inna Nadelwais, Mecomed

Stay Connected